Skip to main content
Clinical Trials/NCT02192593
NCT02192593CompletedNot Applicable

Randomized Controlled Trial of Computerized Cognitive Behavioral Therapy for Auditory Hallucinations in Persons With Psychosis

Boston University Charles River Campus2 sites in 1 country45 target enrollmentStarted: November 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
45
Locations
2
Primary Endpoint
Brief Psychiatric Rating Scale (BPRS)

Study Overview

Brief Summary

This is a randomized controlled trial, examining the effects of a computerized, internet-based Cognitive Behavioral Therapy (CBT) Intervention for persons with a schizophrenia spectrum disorder who experience distressing auditory hallucinations (voices). Participants are randomized to one of two conditions: either to receive the 10-session computer-based program on a weekly basis, or to their usual care at their mental health clinic. This study takes place at Cambridge Health Alliance in Cambridge Massachusetts. It is hypothesized that the participants who participate in the CBT program will have significant improvements in the severity of their auditory hallucinations, as well as their associated distress, compared to the participants receiving usual care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Participants will be on a stable dose of antipsychotic medication for the past 3 months.
  • Schizophrenia-spectrum diagnosis, including schizophrenia, schizoaffective disorder, schizophreniform disorder, and psychosis, not otherwise specified.
  • At least moderate severity on Brief Psychiatric Rating Scale (BPRS) hallucinations item.
  • Naïve to CBTp for Auditory Hallucinations within the past 3 years.
  • No current suicidal ideation or hospitalization within the past month.
  • Reading level of at least 4th grade, as measured by the reading section of the Wide Range Achievement Test (WRAT)
  • Current patient receiving care at Cambridge Health Alliance

Exclusion Criteria

  • Terminal physical illness expected to result in the death of the study participant within one year.
  • Primary diagnosis of dementia or a diagnosis of a psychiatric disorder secondary to a medical condition.
  • Comorbid dementia (severe cognitive impairment) as indicated by a Mini-mental state examination score <
  • Current active substance abuse or dependence with the need for specialized substance abuse services
  • Does not speak English
  • Does not achieve a 4th grade reading level as demonstrated on the Wide Range Achievement Test (WRAT)
  • Has a legal guardian

Outcomes

Primary Outcomes

Brief Psychiatric Rating Scale (BPRS)

Time Frame: Baseline, Post-Treatment, 3-Month Follow-up

Primary outcome is change in BPRS hallucinations item from baseline to post-treatment to 3 month follow-up. This measure assesses severity of auditory hallucinations as well as overall psychiatric symptoms

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Boston University Charles River Campus
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jennifer Gottlieb

Research Assistant Professor

Boston University

Study Sites (2)

Loading locations...

Similar Trials